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INTRODUCTION 
-1-
A new anesthetic, ketamine hydrochloride~ has recently re-: 
ceived considerable attention in the medical profession for use in 
short surgical and diagnostic procedures. Ketamine is described by 
the manufacturer as a non-barbiturate anesthetic formulated as a 
slightly acidic (pH 3. 5- 5. 5) solution and available in concentrations 
1 
of 10, 50 . or 100 mg per milliliter. Among this agent's unique 
properties are the following: selective depression of the higher centers 
of the brain without adversely affecting cardiac and respiratory centers, 
maintenance of protective pharyngeal and laryngeal reflexes, and rapid 
and profound anesthesia. The drug is administered either intravenously 
or intramuscularly and can be used safely without intubation. 
Since its first clinical trials less than ten years ago, ketamine 
has been used in minor surgery, obstetrics, ophthalmology, cardiac 
catheterizations, orthopedics, and burn patients. The results of these 
early clinical trials suggest promise for the use of ketamine in other 
applications but they also point out these undesirable side effects: 
long recovery time, unpleasant postoperative physic reactions, and 
nausea. 
A safe, effective anesthetic agent is urgently needed for pedo-
dontic patients who pose severe behavior management problems. At 
present, medium to high doses of narcotics or barbiturates are most 
commonly used to sedate these patients. However, high doses of 
these drugs pose the threat of respiratory and cardiac depression. 
Consequently, for the patient's safety, it is sometimes necessary to 
admit an unmanageable child to the hospital for a conventional gaseous, 
general anesthetic. Although it may be indicated, a hospital admission 
aKetalar, Park-Davis and Company, Detroit, Michigan. Figure 1. 
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can represent a large expense to the family and a loss in productive 
time for the dentist. 
If the dentist chooses to treat the child as an out-patient with 
local anesthetic plus subanesthetic doses of a central nervous system 
2 depressant, he may choose one of the following~ 
(1) Psychosedatives: diazapam (Valium®), hydroxyzine 
(Atarax®) phenothiazines; (2) Narcotics: meperidine 
(Demerol®); (3} Belladonna derivates: atropine, scopolamine; 
(4) Barbiturates: secobarbital (Seconal®), amobarbital 
{Tuinal®); (5) Nitrous oxide analgesia. 
Even under the best circumstances, it is difficult to determine 
the appropriate dose for a particular patient to produce a sedative 
effect without the inherent danger of central nervous system (CNS) 
depression. When the child is in an acute state of anxiety, a large 
sedative dose with any one or combination of the above agents can be 
hazardous. 
It is most desirable if a drug can be employed which will 
produce profound anesthesia with a minimal dose and still satisfy as 
2 
many of the following criteria as possible. 
(1) Effective analgesia or pain control, (2) partial or 
complete amnesia, (3) patient cooperation, (4) an 
ace es s ible, dry operative field, (5) minimal impair-
ment of the operative field, (6) comfortable positioning 
of the patient, dentist, and anesthetist, and 
(7) complete safety. 
The hypothesis of this study is that by reducing the total amount 
of ketamine that is administered for the anesthesia period, undesirable 
side effects may be reduced, including nausea, post emergence psychic 
reactions and prolonged recovery time. Droperidol and nitrous 
-3-
oxide-oxygen with psychosedative and analgesic properties may be 
effective in combination with ketamine to prolong working anesthesia 
time while reducing these other undesirable side effects. 
This investigation had four principal objectives in the evaluation 
of ketamine for pedodontic out-patient care. The first concern was to 
determine if small doses of ketamine would produce sati sfactory anes-
thesia for sufficient periods to complete dental procedures. Secondly, 
the recovery period was measured, as its length is an important 
factor in out-patient care. A third objective was to compare a series 
of patients anesthetized by a mixture of ketamine and scopalamine with 
this mixture combined with droperidol and this mixture associated with 
nitrous oxide-oxygen. Finally the incidence of complications, side 
effects, and unfavorable operator or parent responses was also assessed. 
The following is a summary of the chemical structure, dosage, 
and commercially available preparations of ketamine .. Ketamine 
• HCl 
hydrochloride! /- dl 2-(o-chlorophenyl)-2-(methylamino) cyclo-
hexanone hydrochloride_/ is available commercially in dosages of 10, 
50, or 100 mg per mL It contains 0. 1 mg/ml Phemerol® (benzethonium 
chloride) as a preservative. The average recommended dosages to pro-
duce surgical anesthesia are 1 mg/lb IV and 3-6 mg/lb IM. 
REVIEW OF LITERATURE 
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Development and Pharmacology of Ketamine 
Ketamine Hydrochloride is a member of the arylcycloalkla-
mines, a class of centrally acting anesthetic drugs. The first general 
anesthetic agent in this family, phencyclidine, was discovered over . 
fifteen years ago. Phencyclidine research was abandoned when 
another member of this class of drugs, ketamine, was shown to have 
fewer side effects. 3 
To determine toxic proportions of ketamine, acute toxicity 
determinations were carried out in rodents and rhesus monkeys by 
4 Kaump et al. Using varying schedules of administration and frequency, 
dosages were increased and the number of surviving animals was re-
corded until toxic levels were reached. Young and old animals were 
used to add another physical variable in the use of the drug. Kaump 
conducted laboratory studies of blood, bone marrow, and serum chemistry 
in both toxic and subtoxic dose states. Autopsy and histological evalu-
ations for drug-related changes in body tissues were also performed. 
The acute toxicity studies were conducted by giving mice and 
rats increasing dosages of ketamine injected intraperitoneally until 
50 per cent or more of the test animals expired. Most deaths, Kaump 
. 4 
and assoctates reported, occurred within two hours of the injection. 
They stated: 
There was initial excitement and irritability, rapidly 
followed by depress ion, severe incoordination, and 
prostration. Recovery followed in reverse sequence .•. 
Complete autopsy examination of a number of rats 
surviving treatment at, or greater than, the LD 50 
values revealed no evidence of organ damage. 
-5-
In Kaump's study the intraperitoneal LD 50 doses ranged from 
229 to 275.4 mg/kg in mice and 146.2 to 248 mg/kg in rats depending 
on age. Although the exact number of test animals is not mentioned, 
the project apparently contained a large sample and the above figures 
represent a good approximation of lethal dosages in these animals. 
In the same study, rodents given ketamine in light to medium dosages 
daily for six weeks showed minor changes in laboratory values, but 
no drug-related gross or microscopic organ damage was noted. Kaump 
also found that after injecting large dosages of ketamine in dogs intra-
muscularly during a period of five days, the righting reflex returned 
in 33 to 54 minutes and hematologic, urine and bone marrow values 
remained normal. Serum chemistry values were also within normal 
limits, except for elevated transaminase values. Kaump hypothesized 
that this increase was related to local muscle injury at the site of in-
jection. In other trials a pair of dogs were given successively higher 
doses up to 160 mg/kg. After the dogs were sacrificed, examination 
showed slight elevation in blood alkaline phosphatase and transaminase 
values but no apparent evidence of organ damage. 
Kaump used an unspecified number of rhesus monkeys in trials 
introducing ketamine intravenously for 1-6 hours in duration in 8 or 
12 doses over a period of 28 or 41 days. There was a slight overall 
decrease in res pi ration, heart rate, blood pressure., and body tempera-
ture. The blood changes were minor with some unspecified incidences 
of leukocytosis, neutrocytosis, and sedimentation increases. Test 
animals showed a return to normal values in 7 to 21 days. Within the 
limitations of the study sample, this animal investigation is probably 
adequate to demonstrate that very high dosages of ketamine are needed 
to produce lethal effects. Even repeated, high, subtoxic dosages failed 
to produce lasting, observable harmful effects clinically or histologi-
cally in the animals studied. 
-6-
5 Chen used several different animal species, varied the dosage 
of ketamine and observed changes in behavioral, electroencephalograph 
(EEG), and cardiovascular values. Initially he noted a characteristic 
behavior, catalepsy, in his animals anesthetized with ketamine in light 
dosages. Catalepsy is a trance-like state of consciousness in which the 
limbs are rigid and retain any position in which they are placed. Chen 
compared the responses of some of his test animals to both ketamine 
and sodium thiamylal, a short acting barbiturate. With the barbiturate, 
catalepsy occurred only during emergence from the anesthetic. Using 
EEG recordings, the barbiturate produced a relaxed, depressed range 
of acti v Lty, whereas the arylcycloalkylamine elicited both a slow and 
excited range of values. No tolerance to repeated administration of 
ketamine was demonstrated as was observed with sodium thiamylal. 
As dosages approached lethal levels with ketamine, Chen re-
ported convulsions in some animals. Barbiturate anesthetics do not 
produce this effect. In the rhesus monkey catalepsy under ketamine 
begins in the lower limbs and then proceeds to the upper regions, 
whereas recovery begins in the upper limbs and proceeds downward. 
The rhesus monkey during recovery was alert and able to turn its head 
well before it was able to direct its lower limbs. Chen pointed out 
that the undesirable psychic effects of the arylcycloa lkylamines in 
human subjects occur during emergence when the subject is begin-
ning to perceive disturbed motor and sensory input and feels a sense 
of being incapacitated. Barbiturates at least provide a degree of 
hypnosis during the emergence period which can mask these dis-
turbing pe ·rc eptions. 
In larger studies with electrodes implanted in the brains of cats, 
Corssen et al6 and Winters et al7 described contrasting EEG effects 
during ketamine anesthesia at various levels of the brain. Corssen 
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found changes in EEG values in the neocortex and subcortical struc-
tures, such as the thalamus, suggesting that the main action of the 
drug is here. However, the limbic system in the hippocampus 
demonstrates increased excitation. Corssen considered that the 
changes in the higher centers of the brain indicate a depressive 
effect, whereas he described the changes in the hippocampus as 
excitatory. For these drug-related changes in the two regions, he 
has popularized the term "dissociative. 11 This concept describes a 
response in which higher centers of the brain appear depressed 
and certain association pathways are interrupted. 
Corrsen et al stimulated the median nerves in test animals 
anesthetized with ketamine and measured potentials reaching the 
somatosensory areas of the cortex. They demonstrated that ketamine 
significantly reduced the somatosensory impulses reaching the cortex, 
but not the midbrain, significantly more than the controls. As Corssen 
pointed out, barbiturates suppress midbrain activity even in low dosages. 
Winters has expressed concern about increased EEG activity in 
the hippocampus in cat and human subjects during ketamine anesthesia. 
He compared these EEG recordings to those seen during epileptic 
seizures. He did not, however, state that ketamine causes actual 
seizures even in epileptics. In fact, Winters described two epileptic 
human subjects who demonstrated seizure activity in the hippocampus 
on EEG recordings but failed to show behavioral signs of any seizures. 
However, after analyzing his results, one would be reluctant to use 
ketamine in an epileptic patient with a history of uncontrolled grand mal 
seizures. 
Winters' study illustrates the principle that general anesthesia 
can be induced by an agent which either depresses or excites the 
central nervous system and therefore renders the subject unresponsive 
to outs ide pain stimuli. In his investigation, Winters placed 16 cats 
-8-
with chronically implanted brain electrodes in a surgical plane 
of anesthesia using ketamine. After evaluating behavioral and EEG 
data, he concluded that ketamine is a CNS excitatory agent which 
renders the subject unresponsive to outside stimuli. 
In a similar study using a cat and a baboon monkey, Szappanyos 
and associates 8 confirmed the findings of Corssen and Winters in 
that the thalmo-cortical system showed increased spike and wave activity 
on the EEG. Moreover, using electrodes implanted in the dura mater, 
he detected an increase in the electrochemical response to visual and 
acoustic stimulations. Also the increased extracortical activities on 
the EEG tracings remained visible for an unspecified time after the 
drug had worn off. 
Conducting in vivo experiments in dogs, Szappanyos measured 
cardiovascular response during IV injections of ketamine in usual 
anesthetic dosages. A depressor-like effect was detected initially in 
cardiac output, blood pressure, peripheral vascular resistance, and 
heart rate. These responses were followed in less than one minute by 
a pressor effect. No indication of any arrythmias was noted on the 
EEG tracing even during injection of ketamine. 
Ketamine produces profound anesthesia by both the IM and IV 
routes of administration. However, as we shall see in clinical studies, 
the IM route requires approximately five times the average dosage to 
9,10,11,12 
produce surgical anesthesia. In a study performed in rats, 
13 Chang determined that the plasma has a smaller binding capacity and 
greater dissociation rate than muscle tissue. He concluded that the 
intravenous route would be the first choice and intramuscular the next 
best route of administration. In the same study, the tissue concen-
trations in an anesthetized animal were found to be 10 times those found 
in the plasma. Chang theorized that it would require a 10 times greater 
dose to saturate body fat before the drug would diffuse into the plasma; 
-9-
therefore the operator should avoid placing an injection of ketamine 
in subcutaneous fat tissue. 
Clinical Trials of Ketamine in Human Subjects 
Although the intravenous method offers more rapid, carefully 
controlled administration of ketamine, intramuscular injection is often 
more feasible for burn patients, small children, infants, or behavior 
bl . 14' 1 5' 16 f pro em patients. Induction o anesthesia usually occurs in 
30-40 seconds by the intravenous route and 3-7 minutes when given 
. 9 14 17 
tntramuscularly. ' ' Nystagmus is commonly observed initially 
. 11 18 
when the eyes are open and ceases after several mtnutes. ' 
The eyelid reflex usually remains, but some patients close their eyes 
. . 17 19,20 
and appear to be tn a deep state of anesthesta. ' Muscle tone 
remains and some involuntary purposeless movements are seen. 
2
' 
6 
20 
Patients are able to swallow their own fluids. Vocalization may 
occur even during periods when the subject is anesthetized deeply 
17, 21 
enough for the procedureii , Laryngeal and pharyngeal reflexes 
h b b . h' 1 1' . t 18' 19 ave een observed to e wtt tn norma tml s. 
Most observers in early clinical studies report an initial in-
crease in blood pressure and heart rate for the first 15-20 
. 2, 8, 9, 14, 16, 17, 22,23 Bl d . 
mtnutes. oo pressure tncreases and 
tachycardia averaged 8. 1 per cent and 4. 3 per cent, respectively, 
in one report of over 1500 anesthetic cases. The intramuscular route 
of administration demonstrated reduced cardiac changes compared 
24 h h . h b 13, 25, 26,27 
to the intravenous means. No arr yt m1as ave een reported 
23 
and one observer stated that ketamine has "antiarrhythmic effects.'" 
Ketamine reportedly produces only mild effects on respiration, 
usually consisting of a mild and transient depression during or soon 
2' 6 ' 9' 2 8 A. . th ff t h after administration. gatn ese e ec s are muc more 
likely to occur after rapid intravenous induction than by the 
-IO-
intramuscular route. Keta.mine apparently does not have a direct 
depressant effect on the respiratory center or secondarily on other 
. f 5,9,28 
resptratory re lexes. Therefore, within therapeutic dosage 
ranges, respiratory depression or sustained apnea has been re-
I8, I9 
ported not to occur. Observers indicate that an orotracheal 
airway or respiratory assistance is unnecessary and that the patient 
is able to maintain adequate spontaneous respiration by breathing room 
. 
20
, 
28 
. 1 d . 1 . 1500 atr. However, 1n a arge stu y 1nvo v1ng over surgical 
procedures, inadequate respiration resulting from excessive sali-
vation or mechanical obstruction during ketamine anesthesia was 
reported for 2. 6 per cent of the cases. 9 Overdoses causing central 
depression ( 1. 3 per cent) and laryngobronchospasm (0~ 4 percent) 
caused other incidents in which respiratory assistance was rendered 
17 
to the patient. Morgan reported the highest incidence of mechanical 
airway obstruction (II. 5 percent). In this study, however 1 the 
anesthetist was able to correct the blockage by adjusting the patient.'s 
head or by using an oropharyngeal airway. In another report using 
26 
ketamine, Brueggemann and Helveston observed one airway ob-
struction in 44 patients. This obstruction occurred in a child with 
Down 1 s syndrome. The anesthetist thought it necessary to intubate 
the patient and continue with a gaseous anesthetic. 
Immediately after administration of ketamine, most observers 
report a generalized increase in muscle tone throughout the body~ 
Such conditions may contraindicate thoracic or abdominal surgery but 
f . . 1 d I4, 29 cause few problems for more super 1c1a proce ures. Oral 
surgeons report the need to maintain the mouth open by mechanical 
6 I8 
aids. ' Purposeless body movements are also seen commonly 
. k . 2, I4, 28 
during some part of a procedure:: us1ng etamtne. Usually 
these movements occur as the subject is beginning to emerge or has 
6, IO, 12 
been given an insufficient dose. Although these movements 
-11-
are generally not enough to warrant concern, ketamine is considered 
unsatisfactory by some authors for orthopedic and eye surgery or 
other deep or long-term surgical procedures where absolute im-
b 'l't . t' 1 21,26 mo 1. 1. y I.S essen I. a 0 
One of the interesting side effects observed by clinical in-
vestigators was a certain incidence of psychic reactions by the 
patient during emergence. As discussed previously, studies by 
5 7 Chen and Winters described enhanced activity in the central nervous 
system as recorded by EEG tracings. Unlike other general anesthetics 
which provide a sedative or hypnotic effect during recovery, ketamine 
causes a greater amplitude of sensory input. 
Clinically, many observers report a varying incidence of vivi.d 
dreaming or in some cases hallucinations by subjects during 
22 30 
emergence. ' These dreams may be pleasant or unpleasant. 
During this period the subject may vocalize or move, indicating 
a phase of vivid dreaming. In one study of 138 anesthetic cases, with 
patients aged from 2 months to 89 years, 33 per cent could not recall 
17 T . d what the dreams were about. wenty patients state that they had 
experienced pleasant dreams; however, 10 per cent of the patients 
in this study recalled "vivid, frightening dreams" and indicated 
that they would not undergo anesthesia with the same agent again. 
17 Morgan pointed out that of the 32 children in this report under the 
age of 14, only one recalled dreaming and this dream was not 
frightening. The patients who described frightening experiences had 
been given IV administrations. The children were given the agent 
intramuscularly due to the greater ease of administration~ 
Corssen 9 emphasized the importance of not disturbing the 
patient during the recovery period. He maintained that the patient 
is still in a dissociated mental state and incapable of relating 
normally to his environmento 
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Attempts to arouse the patient while he is still 
unable to see and hear and to orient himself may 
set in motion a chain of anxiety reactions which 
ultimately can lead to severe psychomotor out-
breaks and irrational behavior. 
Corssen stated that during recovery the patient should be shielded 
from any outside verbal, light, or tactile stimuli. Although this 
aspect was not an objective of his study, Corssen observed that most 
psychic disturbances were seen in adult patients and usually resulted 
when premature attempts were made to awaken them. After evalua-
ting 1508 cases, he reported an overall incidence of 2. 8 per cent of 
vivid dreaming and 0. 20 per cent incidence of hallucinations. 
Applications to Outpatient Dental Procedures 
Ketamine HCl only recently began to be studied for its 
suitability for oral surgery and restorative dentistry. In an oral 
surgery study of 115 patients aged l to 58 years with an average age 
of 7 years, Corssen and Hayward administered ketamine IV in 112 
procedures at 0. 25-1 mg/lg and IM in 3 cases at 5 mg/lb. 
6 
No 
local anesthetics were employed. A transient respiratory depression 
was sometimes observed during rapid IV administration and increased 
salivary activity was reported. Increased secretions in the bronchial 
tree and in the oral cavity presented a danger of aspiration of fluids 
in the lungs and decreased gaseous exchange. Afterward an anti-
sialagogue, scopolamine, was given IM 15-20 minutes before the 
18,19,31 
ketamine. As in other reports, Corssen confirmed the 
maintenance of protective swallowing reflexes and the fact that an 
orophryngeal or orotracheal airway was not needed. Although no 
vomiting was encountered during anesthesia, six patients vomited 
during the recovery period, perhaps due to the swallowing of blood. 
6
' 
32 
-13-
In the same study, Corssen recorded the average time inter-
val from the intravenous administration of ketamine until the patient 
could walk unaided. 
time was 42 minutes. 
Using a dose of 1 mg /lb, the average recovery 
Reducing the dosage to as little as 1/4 mg/lb 
IV did not significantly reduce the average recovery time. This is 
a remarkable and unexpected response and the authors were unable 
to account for these results. 
Sever_al studies have reported that the working time for the 
IV route (10-15 minutes} was far shorter than for the IM route 
(20 40 . ) 6, 10,12,33 . - mLnutes • As mLght be expected, the recovery 
time for IV administration (40-60 minutes} was also much shorter 
h ) 6,10,12,33 t an for IM ( 120-180 minutes • Using the IM route 
18 
exclusively, Birkhan demonstrated a longer average recovery time 
of 3-l/2 hours. However, he defined recovery more strictly as 
11full ambulation and orientation. 11 Birkhan also reported a low inci-
dence of vomiting (4%) of 25 cases and no unpleasant emergence 
reactions. 
Another oral surgeon, Hellinger
19 
used ketamine in a study 
of fifty adult patients because the respiratory and cardiovascular 
systems and the protective reflexes were maintained with this agent; 
however, due to a relatively high incidence of severe hallucinations 
( 14%) and unpleasant vivid dreaming, he recommended limiting its use 
to patients with cardiovascular or respiratory disease. All studies 
mentioned here used similar recommended dosages of 1/2 -1 mg/lb 
IV and 4-6 mg/lb IM. 
Two researchers attempted to use ketamine IM in smaller 
dosages, 0. 5 - 1. 5 mg/lb to obtain light anesthesia and analgesia 
11,33 . 
and reduce the length of recovery time. UsLng ketamine, 
33 
atropine, and local anesthetic, Shane performed oral surgery and 
restorative dentistry on an unspecified number of children. Tpe 
-14-
report included only the clinical impressions of the author, who 
thought the lessened dosage was unsatisfactory to complete his pro-
cedures. Shane thought that although the patient might be able to 
hear quite well, he seemed unable to control his exaggerated muscular 
uncoordination. Shane described the subject as being still in a re-
covery-like state and being disturbed by the noise of the high speed 
and suction and the pressure of the biteblock and extractions. 
On the other hand, in a more recent oral surgery study with 
. 11 . 700 patients, Greenfteld combtned small dosages of ketamine with 
nitrous oxide analgesia (with a limit of 50% nitrous oxide) and re-
corded satisfactory working t ~me of 10-35 minutes, combined with a 
shortened recovery time of 5-30 minutes. Greenfield did not outline 
the criteria for recovery but described it as the point for discharging 
the patient. As no adverse psychic reactions or other complications 
were reported and the recovery time was effectively shortened, it 
appears that this method of administration should be explored as a very 
desirable method of anesthesia. 
Agents Which May Supplement Ketamine Anesthesia 
. 1, 16, 28, 34, 35, 36 
In several studies, dropertdol has been 
suggested as a means to reduce unpleasant side effects of ketamine 
such as vomiting and psychic reactions. It has also been suggested 
that a combination of nitrous-oxide and ketamine, such as is used in 
medical surgical applications, might be useful in shortening the re-
. 9 11 37 
covery time by making repeat injections of ketamtne unnecessary. ' ' 
Droperidola is a butyrophenone and is used as a powerful 
tranquilizer, an antiemetic, and an adreneric blocking agent. When 
it has been combined with ketamine, certain clinical observers have 
. d t t• . . 34, 35, 38 
noted the absence of hallucinations an pos opera 1ve vomtttng. 
One observer suggested that the tachycardia effects of ketamine may 
ainapsine, McNeil Laboratories, Inc. Fort Washington, Pa. Figure 1. 
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be countered by the bradycardia effects of droperidol. 35 
34 
Sadove et al used sixty patients in a double blind study, 
giving droperidol preoperatively in three dosage ranges: 0. 03 mg/lb, 
0. 06 mg/lb, and 0. 12 mg/lb. A fourth group was given saline solution 
as a control. Each patient received a ketamine anesthetic in standard 
surgical dosages. This group of investigators found that droperidol had 
no significant influence on such side effects of ketamine as muscle 
rigidity, hypertension, and tachycardia. However, hallucinations, 
nausea, and vomiting were significantly lower in the droperidol groups 
and the higher dosages of droperidol reduced "bad" or unpleasant 
dreaming by more than half. 
For dental out-patient applications, nitrous oxide-oxygen 
analgesia is usually administered by a nose mask at concentrations 
2 39,40,41 of 0-50 per cent. . Following administration of moderate 
f .d h . d d •t f . 39, 40,41 amounts o nitrous ox1 e, t ere lS a ec reas e acu1 y o pa1n. 
The principal effect of nitrous oxide is analgesia and the analgesic 
d . h . 40 potency increases in accor ance w1t gas concentration. It is 
commonly accepted that the action of the nitrous oxide in the blood 
stream is a purely physical one and that no chemical combination 
41,42 
takes place with the tissues. In their review of the literature, 
Hogue, Ternisky, and Iran pour noted that various other clinical 
observers had reported from 40 to 58.8 per cent incidences of nausea 
and vomiting with 40% nitrous oxide-oxygen concentration in adminis-
40 
trations of over 30 minutes. Therefore, we can assume that ad-
ministration of nitrous-oxide enhances the possibility of vomiting 
during the procedure. 
Although droperidol has been shown to reduce the incidence of 
vomiting and unpleasant psychic reactions, no studies evaluating either 
droperidol or nitrous oxide w.ith ketamine for dental out-patient pro-
cedures have been reported. Several studies illustrate the cardiovascular 
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39,40,42 
changes that occur under nitrous oxide administration. 
These include an increase in oxygen level of the blood, a decrease in 
heart rate and output, and a decrease in arterial pressure. 
Everett and Allen39 observed that these physiological responses are 
similar to those of a patient on oxygen alone. 
Therefore, nitrous oxide used in combination with ketamine 
might be expected to enhance analgesia, provide a potential for 
nausea, and result in favorable cardiovascular responses. 
METHODS AND MATERIALS 
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Sixty patients for this study were selected from out-patients at 
the Dental Clinic of the James Whitcomb Riley Hospital for Children 
in Indianapolis, Indiana. These patients were chosen to receive a· 
general anesthetic for their dental treatment because they exhibited 
one or more of the following: 
a. Severe apprehension and resistance in the emotionally 
disturbed child with multiple carious teeth after treat-
ment with sedation had been attempted. 
b. Mental retardation with inability to obtain minimal 
cooperation. 
c. Significant physical handicaps such as cerebral palsy 
which prevented the patient from cooperating. 
d. Multiple carious teeth in the very young preschool child 
who was non-communicative and uncooperative. Usual 
techniques of behavior management and sedation had 
been unsuccessful. 
These patients ranged in age from 19 months to 23 years, with 
a mean age of 7. 8 years. Each patient was randomly scheduled to 
receive one of three combinations of ketamine designated as either 
Treatment I, Treatment II, or Treatment III. 
Treatment I ketamine HCl 2 mg /lb 
Treatment II 
Treatment III 
a Figure 2. 
scopolamine 
ketamine HCl 
scopolamine 
drape ridol 
ketamine HCl 
scopolamine 
a 
nitrous oxide-oxygen 
• 1-. 3 mg 
2 mg/lb 
. 1-. 3 mg 
• 025 mg/lb 
2 mg/lb 
• 1-. 3 mg 
20-SOo/o 
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Treatment I served as the control in this study and was the bas is 
of comparison for the other groups, since ketamine and scopolamine were 
used consistently in each treatment. The dosage of ketamine was the 
same for each of the three groups (2 mg/lb). Scopolamine was given 
as a mixture with ketamine in the same syringe by an intramuscular 
(IM) injection in the patient's lateral thigh. Scopolamine was chosen 
for antisialagogue and minor hypnotic effects, as recommended by . 
1,6,9,20,43 . 
previous mentioned reports. Dropertdol was administered 
IM in Treatment II in the lateral thigh musculature immediately after 
ketamine and scopolamine. A tuberculin syringe (1 cc) was generally 
useful to inject the small quantities of droperidol necessary(. 1-1. Occ). 
In Treatment III, nitrous oxide was administered after the start 
of anesthesia with ketamine using a semiclosed apparatus with a nose 
mask (Figure 2). The gaseous ratio of nitrous oxide-oxygen was de-
pendent on the need to maintain the patient in a quiet state. A more 
resistive patient received a maximum of 50 per cent nitrous oxide 
until more relaxation resulted. Afterward the level of nitrous oxide 
was reduced. 
After a medical history ruled out a history of cerebral vascular 
1 . 1, 7 . I accident or uncontrolled grand rna setzures, the chtld s parents 
were instructed not to give the child any food after six hours before 
the dental appointment (Instructions for Parents Concerning Sedation, 
Exhibit # 1 in Appendix). This precaution minimized the possibility 
of nausea and vomiting during anesthesia. The parents were also 
informed that the child would receive the general anesthetic by in-
jection in the leg and after the dental treatment they would be asked to 
stay with him until he was able to return homeo 
A pilots tudy including over fifty pedodontic patients was com-
pleted to determine the minimum dosage of ketamine to be adminis-
tered IM for at least 30 minutes of anesthesia working time. Dosages 
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less than 2 mg/lb were found unsatisfactory to produce this desired 
period of anesthesia consistently; therefore, 2 mg/lb of ketamine 
IM was maintained during the controlled portion of the study. Ac-
1 
cording to the manufacturer, the accepted IM dose for surgical 
procedures is in the range of 4-6 mg/lb; consequently, the amount 
of anesthetic administered was still far below the usual accepted 
dosage. Since ketamine in low dosages does not usually produce 
surgical anesthesia, a local anesthetic, Xylocaine® (2% solution with 
1:100,000 epinephrine), was also administered in the area of treat-
ment. 
The working time was measured from the time when the first 
injection was administered until the procedure was completed or a second 
injection was necessary. Additional injections were given when the 
patient began movements which made restorative dentistry difficult 
(the beginning of emergence). 
Pre and Post Treatment 
The mental status of each patient was evaluated as he entered 
the dental clinic treatment room by the same investigator (the author). 
The patient was classified as normal, slow or retarded according to 
the following criteria: 
1. Normal--a child presently attending school and in the 
2. Slow---
expected grade level for his age or a pre-
school child with a history of no learning dis-
abilities and normal speech. 
a child presently attending special education 
classes for educable or trainable rated intel-
ligence. A child who demonstrates ability to 
dress himself or become toilet-trained. 
3. Retarded- a chiid classified as mentally retarded by a 
physician or special educator who fails to 
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demonstrate even minimal comprehension 
or cooperation in a dental chair. 
In addition to the preassessment of the patient's mental status, 
he was evaluated preoperatively according to a consistent series of 
physical and mental tasks and given a score according to the following 
objective c1·iteria (Physical and Mental Measurement Form, Exhibit 
# 2, in Appendix). 
1~ a. Motor coordination and gait (3 points): 
Good - essentially normal, able to walk well unaided. 
Fair - s orne disability, able to walk but somewhat un-
steady. 
Poor- marked disability, unable to walk without aid. 
Unsatisfactory - unable to walk even with aid. 
b. Entry to chair (3 points): 
same criteria as above 
2. Memory score (5 points): 
The patient is as ked to identify items in a series of five 
colorful pictures with easily recognizable objects including 
an automobile, horse, bird, Indian, and rabbit. 
3. Finger-finger and finger-nose test (4 points): 
The subject's coordination is measured by asking him to touch 
two index fingers of each hand together and to touch the nose 
with eyes open and closed. 
4. Response to commands (3 points): 
The patient is asked to hold up his hand, open his mouth, or 
close his eyes. 
5. Color discrimination (3 points): 
The patient identifies.three different color panels, red, blue 
and yellow. 
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6. Counting procedure (3 points): 
The patient determines how many fingers the evaluator is 
holding up. 
The total number of points for complete performance of the physical 
and mental measurements is 24. The mean scores of the preoperative 
mental and phys ica.l evaluation tests were as follows: 
l. 
2. 
3. 
Normal 
Slow · 
Retarded 
15.8 
1 o. 0 
4. 1 
Following dental treatment and during recovery, the same investigator 
evaluated the physical and mental abilities of the patient at 30-minute 
intervals. The motor coordination and gait (Item 1) was the most 
reliable measurement to compare patients with differing test scores. 
This item was always the last measurement which the patient could 
perform satisfactorily. When the patient was able to equal his pre-
operative score, he was judged fully recovered from the anesthesia 
and discharged to the parent's care. 
Operating Procedure 
After preoperative tests were completed, the anesthetic in 
Treatment I, II or III was administered IM. The time required for 
the onset of anesthesia was recorded. The arrival of the anesthesia 
a 
was identified by a fixed stare and catalepsy. The local anesthetic 
was given according to the usual methods of local nerve blockage for 
b 
dental procedures within accepted dosages. All restorative treat-
ment was performed by pedodontic interns, residents or faculty. A 
rubber dam was used to prevent aspiration of foreign particles and to 
minimize stimulation of the posterior wall of the pharynx. A mouth 
prop was generally necessary as some rigidity of the masticatory 
a F. tgure 5. 
b Figure 6. 
a 
muscles was usually present. 
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In the event of any complication during anesthesia, complete 
resuscitation equipment was available including positive ventilation 
oxygen (Figure 3), airways and orotracheal tubes, laryngoscope, 
intravenous catheters, and emergency drugs such as epinephrine and 
succinylcholine. The clinic dentists and auxiliaries were instructed 
on how to summon assistance for such emergencies as laryngospasm 
or cardiac arrest. An Indiana University staff anesthesiologist was 
immediately available if a serious emergency developed. 
The restorative procedures were usually limited to 90 minutes. 
Afterward, the patient was moved to a darkened recovery room to 
stay with the parent until dismissal (Figure 4). Previously the parents 
had been given written instructions not to stimulate the child verbally 
or tactilely during recovery to avoid emergence reactions. All pro-
cedures were documented by the same investigator, including medical 
status of the patient, pulse and respiration, course of the anesthetic, 
drug dosages, treatment and recovery time, arrl side effects or 
complications (Ketamine Evaluation Form, Exhibit #3, in Appendix). 
The operata r was asked to give his clinical impress ion of the quality 
of the anesthesia. If the patient was quiet or relatively quiet through-
out the procedure, he rated the anesthetic excellent; if the patient 
moved but adequate restorative dentistry could be performed, he 
considered the anesthesia good. A rating of fair indicated improve-
ment in behavior but s orne difficulty was encountered. The operator 
rated the anesthetic poor if some serious problems were encountered 
making the anesthetic unsatisfactory. 
The parents were given a questionnaire form and instructions 
to complete it relative to the patient's travel home and for the first 
24 hours following dismissal from the clinic (Sedation Questionnaire 
Form, Exhibit #4 in Appendix). The form was to be returned to the 
a 
Figure 7. 
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James Whitcomb Riley Hospital Dental Clinic in a self-addressed, 
stamped envelope. 
RESULTS 
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A statistical analysis was performed on the data obtained for 
the three treatments to measure significant differences in Treatment 
I, II or III on the basis of working time and recovery time. In ad-
dition, the relationship of intelligence, as measured by the patient's 
test scores, to working time and recovery time in each of the three 
treatments was examined. 
Using analysis of variance, significant differences were found 
when comparing test scores and working times between the various 
groups but not for recovery times. Further "t"" tests using the Newman-
Keuls method recorded significantly longer working time and higher 
intelligence in Treatment III, whereas recovery and working times as 
well as intelligence were not significantly different in other treatments. 
The results of each anesthetic case are recorded in Table I 
including the number of injections of ketamine, working time under the 
anesthetic, recovery time, and the patient's test score. The mean 
working and recovery times are recorded in Table II according to 
treatment and according to intelligence. 
Table III is a summary of statistically significant values as 
measured at the . 05 level of confidence. Working time, recovery 
time, and test scores are compared according to treatment and intel-
ligence. Tables IV-XII include a detailed statistical analysis of all 
three variables using analysis of variance and N ewman-Keuls "t" 
tests. 
A mixture of ketamine and scopolamine, or ketamine, scopola-
mine, and droperidol was used initially, but all subsequent .'injections 
used ketamine alone. The time of onset of anesthesia from the first 
injection ranged from 3-7 minutes with an average of 5 minutes in all 
three groups. The total number of injections necessary to provide 
satisfactory anesthesia in 60 minutes of working time was recorded. 
A linear relationship was found in comparing the number of injections 
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with intelligence. Whereas the dental procedures for 50 per cent of 
the normal group were completed with one injection, 56 per cent of the 
slow group and 73 per cent of the retarded children were completed 
with only one injection (Table XIII). In Table XIV, a marked decrease 
in the number of repeat injections necessary was found in Treatment 
III vs. Treatments I and II. 
The incidence of complications was recorded according to 
treatment and intelligence: normal, slow, and retarded (Table XV). 
Only one child vomited during the anesthetic . This incidence caused 
no particular difficulty as the patients 1 normal laryngeal reflexes 
were present and the anesthetic was administered on an empty 
stomach. The single incident of a parent reporting her son hal-
lucinating occurred in a 23-year-old retarded patient weighing 179 
pounds. Although the recovery period was uneventful, the mother 
later responded with dissatisfaction due to difficulty in handling her 
irritable son during the post-emergence period. 
A blockage of the airway was encountered with three Down 1 s 
Syndrome patients in both Treatments I and II. All three patients 
exhibited macroglossia and relative prognathism characteristic of 
this syndrome. A single incident of a partiallagyngospasm was re-
corded in a 12-year-old normal female. The patient reported a 
history of a recent common cold but exhibited no nasal congestion 
and was afebrile at the time of anesthesia. The patient was resusci-
tated immediately with no difficulty using positive oxygen ventilation 
alone. No pattern of complication compared to treatment or intelligence 
was observed. 
The operator's responses to each of the three combinations of 
ketamine were consistently high, with most operators reporting 
excellent or good anesthesia (:Table XVI). 
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Among the questions on the Sedation Questionnaire Form 
(Appendix #4) were these: "Did you have any difficulty managing your 
child after you got home? 11 and "Do you feel that this method of 
sedation was favorable or unfavorable for your child's dental treat-
ment? 11 With 80 per cent of the questionnaires returned, 85 per 
cent of the parents responded favorably, 12 per cent unfavorably, and 
3 per cent were unsure (Table XVII). No large difference in favorable 
or unfavorable response was noted from parents according to which 
treatment the child received. 
ILLUSTRATIONS 
Figure l. 
Figure 2. 
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Commercial preparations of the injectable agents 
used in the study: droperidol, scopolamine, and 
ketamine. 
Chemetron nitrous oxide-oxygen analgesia apparatus 
used in the study. This machine, manufactured by 
National Cylinder Gas,is semiclosed and uses a 
nose mask. 

Figure 3. 
Figure 4. 
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Puritan positive pressure oxygen apparatus 
used for emergency resuscitation. 
Recovery facility used for patients during the 
recovery period. This area should be kept dark 
and quiet to avoid unpleasant reactions by the 
patients. 

Figure 5. 
Figure 6. 
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Patient anesthetized with ketamine. This patient 
demonstrates clinical signs of catalepsy and 
aimless staring characteristic of ketamine 
anesthesia. 
Local anesthetic being administered to patient 
anesthetized with ketamine. Masticatory muscles 
are rigid necessitating the use of a mouth prop. 

Figure 7. 
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Anesthetized patient ready for restorative 
dentistry. Nitrous oxide nose mask, rubber 
dam, and mouth prop are in place. Cotton 
gauze squares are placed over the eyes to 
avoid debris and light stimulation. 

TABLES 
Table I 
Raw Data on Number of Injections, Working Time, Recovery Time, and Test Scores 
First figure - number of injections of ketamine HCl 
Second Figure- working time under anesthetic 
Third figure - recovery time from last injection 
Fourth figure - patient test score 
Normal Slow Retarded 
Treatment I 
1' 60' 195, 11 2, 35, 93, 6 2, 20, 105, 2 
2, 14, 138, 6 1, 60, 88, 8 1, 6 0, 150, 6 
2, 6 0, 120, 15 1, 50, 105, 4 1 , 6 0, 135, 4 I 
v.> 
2, 11, 128, 14 1' 40, 120, 4 1, 3 0, 7 5, 0 1-' I 
1, 70, 204, 6 1, 30, 127, 0 
2, 3 7, 150, 2 
3, 2 7, 15 0, 4 
3, 48, 150, 4 
1, 60, 150, 4 
1, 60, 158, 4 
2, 11, 15 2, 6 
Treatment II 
+ 1 , 6 0 , 90, 6 2, 52, 145, 0 2, 25, 95, 0 
2, 3 0, 126, 24 3, 30, 105, 6 1 , 40, 146, 0 
2, 20, 155, 6 3, 15, 95, 6 1, 60, 195, 2 
2, 30, 128, 24 2, 60, 13 7' 6 1 J 80, 16 9, 6 
1, 6 0, 192, 13 1, 40, 135, 24 1 , 6 0, 130, 2 
2, 60, 145, 6 1, 25, 13 0, 6 
2, 3 5, 180, 0 
1, 40, 122, 6 
2, 0, 240, 6 
Table I (continued) 
Raw Data on Number of Injections, Working Time, Recovery Time, and Test Scores 
First figure -number o£ injections of ketamine HCl 
Second figure - working time under anesthetic 
Third figure - recovery time from last injection 
Fourth figure - patient test score 
Normal 
+ l, 6 0 , 16 0, 24 
1, 80!t- 120, 24 
1' 6 .o +' 210, 24 
2' 6 0 +' 115' 6 
1, 60 ' 150, 24 
Slow 
Treatment III 
3, 24~ 155, 22 
1, 60 ' 143, 18 
+ 1, 60+, 135, 6 
1' 6 0 J 86 J 4 
1, 60+, 120, 24 
1, 6o+, 124, 6 
1, 60+, 240, 24 
Retarded 
1, 90!j- 135, 6 
1, 60 , 132, 12 
1, 60+, 132, 6 
1, 40, 200, 6 ,_ 
1 , 6 0 +' 1 55, 6 
1, 60+, 96, 2 
1 , 6 0 +' 1 2 8 J 6 
1, 60 , 155, 2 
I 
lN 
N 
I 
Table II 
Means of Working Time and Recovery Time Across Treatments and Intelligence Levels 
Normal Slow Retarded 
Mean W.T. R.T. W.T. R.T. W.T. R.T. 
(Min.) (Min.) (Min.) (Min.) (Min. ) (Min.) 
Treatment I 36.25 145.25 51.00 122.00 40.27 136.55 
Treatment II 40o00 138.20 42.83 127.00 40.55 156.22 
Treatment III 64.00+ 151.00 54.86+ 143.28 61.25+ 141.63 
Average 47.50+ 142.64 49.78+ 131.94 47.27+ 146.87 
I 
Working Time Average Recovery Time w 
w 
Treatment I 42. 15 min. 134.65 min. 
I 
Treatment II 41. 10 min. 143. 00 m in. 
Treatment III + . 59. 70 mtn. 144. 55 min. 
Table III 
Summary of Significant Differences in Working Time, Recovery Time, and Test Scores Across 
Treatments and Intelligence Levels . 
Working Time 
Recovery Time 
Test Score 
Working Time 
Recovery Time 
Test Score 
I - II 
N.S.D. 
N.S. D. 
N.S.D. 
Norm-Slow 
N.S.D. 
N.S.D. 
* 
*Significant difference measured at • 05 level. 
I - III 
Treatment 
N.S.D. 
Intelligence Level 
N arm-Retard 
N.S.D. 
N.S.D. 
II - III 
N.S.D. 
Slow-Retard 
N.S.D. 
N.S.D. 
I 
VJ 
.p.. 
I 
Table IV 
Working Time Means, Standard Deviations, and Analysis of Variance Across Both Treatments 
and Intelligence Levels 
No. of Mean Std. Dev. 
Cell Re s 0 y y 
IN 4 36.25000 27.45147 
2S 5 51.00000 14.31782 
3R 1 1 40.27273 18. 11679 
4N 5 40.00000 18.70829 
5S 6 42.83333 18.00463 
6R 9 40.55556 23.64377 
7N 5 64~00000 8.94427 
8S 7 54.85714 13.60672 
9R 8 61.25000 13.56203 
Analysis of Variance Table 
Source Sum of Mean 
Sguares D.F. Sguare F 
Mean 124972.53 1 124972.53 384.54608 
Treatments 4157.5759 2 2087.7879 6. 42422~c 
Intelligence NSR 75. 198416 2 37.599208 .11569 NSD 
Interaction 837.72839 4 209.43210 . 64443 NSD 
Error 16574.345 51 324.98715 
>:C Significance measured at • 05 level. 
I 
w 
U1 
I 
Table V 
Working Time Mean, Standard Deviation, and Neuman-Keuls "t 11 Tests For Significant Difference 
Across Treatments 
Group Count 
Treatment I 20 
Treatment II 20 
Treatment III 20 
Total 60 
Subset 1 
Group Group 2 
Mean 41. 1000 
Subset 2 
Group Group 3 
Mean 59.700 
~:'Significance measured at. 05 level. 
Group 1 vs Group 2: N.s·.n. 
Group 1 vs Group 3: ;~:: 
Group 2 vs Group 3:* 
Standard 
Mean Deviation 
42.1500 19.1016 
41. 1000 19.8942 
59.7000 12.5535 
47.6500 19.2282 
Group 1 
42.1500 
I 
lN 
0' 
I 
Table VI 
Working Time Means, Standard Deviation, and Ne\uman-Keuls 11 t 11 Tests for Significant Differences 
Across Intelligence Levels 
Group 
Normal 
Slow 
Retarded 
Total 
Subset 1 
Group 
Mean 
Group 1 vs Group 2: N.S.D. 
Group 1 vs Group 3: N.S.D. 
Group 2 vs Group 3: N.S.D. 
Count 
14 
18 
28 
60 
Norm 
47.5000 
No significant differences were found. 
Mean Standard Deviation 
47.5000 21.7141 
49.7778 15.3950 
46.3571 20.6617 
47.6500 19.2282 
Slow Retard 
49.7778 46.3571 
I 
L.V 
-J 
I 
Table VII 
Recovery Time Means, Standard Deviations, and Analysis of Variance Across Both Treatments 
and Intelligence Levels 
Cell 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Source 
Mean 
Treatment 
Intelligence 
Interaction 
Error 
No. of 
Reps. 
4 
5 
11 
5 
6 
9 
5 
7 
8 
Sum of 
Squares 
1070082.7 
1022.7945 
2449.2933 
2562.7396 
68517.581 
Significance measured at. 05 level. 
Standard 
Mean Deviation 
145,25000 33.97425 
122. 00000 47.47104 
136.54545 25.45727 
138.20000 37.92361 
127.00000 21.54066 
156.33333 44,22952 
151.00000 38. 14446 
143.28571 47.88080 
141.62500 29.90909 
Analysis of Variance Table 
Mean 
D. F. Square F 
1 1070082.7 796.4995 
2 511.39724 . 38 06 5 
2 1224.6467 .91155 N.S.D. 
4 640.68491 .47688 N.S.D. 
51 1343.4820 
I 
VJ 
00 
I 
Table VIII 
Recovery Time Mean, Standard Deviation, and Neuman-Keuls 11 t 11 Tests for Significant Differences 
Across Treatments 
Group Count 
Treatment I 20 
Treatment II 20 
Treatment III 20 
T·otal 60 
Subset 1 Group T-1 
Mean 134.6500 
No significant differences were found. 
Group 1 vs Group 2: N.S.D. 
Group l vs Group 3: N. S.D. 
Group 2 v s Group 3: N. S. D. 
Mean 
134.6500 
143.0000 
144.5500 
140.7333 
T-2 
143.0000 
Standard 
Deviation 
32.6437 
37.6787 
37.0810 
35.5298 
T-3 
144.5500 N.S.D . 
I 
VJ 
-...() 
I 
Table IX 
Recovery Time Means, Standard Deviation and Ne·uman-Keuls 11 t 11 Tests for Significant Differences 
Across Intelligence Levels 
Group Count 
Normal 14 
Slow 18 
Retarded 28 
Total 60 
Subset 1 
Graue Normal 
Mean 131.9444 
No significant differences were found. 
Group 1 vs Group 2: N.S.D. 
Group 1 vs Group 3: N.S.D. 
Group 2 vs Group 3: N. S.D. 
Standard 
Mean Deviation 
144.7857 34.4700 
131.9444 39.5794 
144.3571 33.5628 
140.7333 35.5298 
Slow Retarded 
144.3571 144.7857 
I 
~ 
0 
I 
Table X 
Test Score Means, Standard Deviation, and Analysis of Variance Across Both Treatments and 
In tellig enc e Levels 
No. of Standard 
Cell Reps. Mean Deviation 
1 4N 11. 5 4.0 
Treatment I 2 5S 5.6 1. 6 
3 11R 3.8 1. 8 
4 5N 14.6 9.0 
Treatment II 5 6S 8.0 8. l 
6 9R 3. 1 2. 8 
7 5N 20.4 8. 0 I 
..p.. 
Treatment III 8 7S 14.8 9. 1 ~ I 
9 8R 5.7 3. l 
Analysis of Variance Table 
Sum of Mean 
Source Squares D. F. Square F 
Mean 80.5 1 80.5 2.5 
Treatment 378.0 2 189.0 5. 9 ):~ 
In tell ig enc e 1218.5 2 609.2 19. 1 ~~ 
Interaction 112. 3 4 28.0 . • 8 - N.S.D. 
Error 1555.7 49 31 .. 7 
'~ Significance measured at • 05 level. 
Table XI 
Test Score Mean, Standard Deviation, and Neuman-Keuls 11 t 11 Tests For Significant Differences 
Across Treatments 
Group Count 
Treatment II 20 
Treatment I 20 
Treatment III 20 
Total 60 
Subset 1 
Group Treatment II 
Mean 5.8000 
Subset 2 
Group Treatment III 
Mean 12.6000 
~:~ Significance measured at • 05 level. 
Group 1 vs Group 2: N.S.D. 
Group 1 vs Group 3: '~ 
Group 2 vs Group 3: >.~ 
Standard 
Mean Deviation 
5.8000 3.7641 
7.4500 7.7966 
12.6000 9.0169 
8.6167 7.6714 
Treatment I 
7.4500 
I 
~ 
N 
I 
Table XII 
Test Score Means, Standard Deviation, and Neuman-Keuls "t" Tests for Significant Differences 
Across Intelligence Levels 
Group 
Normal 
Slow 
Retarded 
Total 
Subset 3 
Group 
Mean 
Subset 1 
Group 
Mean 
Count 
14 
18 
28 
60 
Normal 
15.7857 
Retarded 
4. 1429 
~:~ Significance measured at . 05 leve 1. 
Group 1 vs Group 2: ):c 
Group 1 vs Group 3: ):~ 
Group 2 vs Group 3: )!< ' 
Standard 
Mean Deviation 
15.7857 7.9535 
10.0000 8. 1746 
4. 1429 2.7178 
8.6167 7.6714 
Subset 2 
Group Slow 
Mean 10.0000 
I 
..p.. 
VJ 
Table XIII 
Number of Injections Received in Each Treatment Group Across Intelligence Levels 
First Column- number of patients receiving one injection. 
Second Column - number of patients receiving two injections. 
Third Column- number of patients receiving three injections. 
Normal Slow Retarded 
Treatment I 1,3 (25%, 75%) 4, 1 (80%, 20%) 6, 3, 2 (55%, 27%, 18%) 
Treatment II 2, 3 (40%, 60%) 1, 3, 2 (17%, 50%, 33%) 6, 3 (67%, 33%) 
Treatment III 4, 1 (80%, 20%) 4, 0, 1 (80%, 0%, 20%) 10, 0 (100%, O%) 
Total 7, 7 (50%, SO%) 9, 4, 3{56%, 25%, 19%) 22, 6, 2(73%, 20%, 7%) 
Parenthesis -above figures translated to percentages. 
I 
~ 
~ 
I 
Table XIV 
Patients Requiring More than One Injection of Ketamine Across Treatments and Intelligence Levels 
Treatment I 
Treatment II 
Treatment III 
Normal 
3 
3 
1 
7 I 14 (50. O%) 
Slow 
l 
5 
1 
7/18 (38.9%) 
Retarded 
5 
3 
0 
8/28 (28. 6%) 
9/20 (45%) 
ll /20 (55%) 
2/20 (10%) 
I 
~ 
Ul 
I 
Table XV 
Complications Noted Across Treatments and Intelligence Levels 
T-1 T-2 T-3 
Vomiting op o, o 0, 0, 0 0, 0, l 
Hallucinations 0, 0, 0 0, 0, 0 0, 0, l 
Tongue blocking airway 0, 0, 2 0, l, 0 0, 0, 0 
Other airway obstruction 0, 0, 0 0, 0, 0 l, 0, 0 
2 l 3 
Column l are normal, column 2 slow, column 3 retarded under each treatment. 
Total number of complications by intelligence level: 
Normal l 
Slow l 
Retarded 4 
I 
..p:.. 
0" 
I 
60 
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Table XVI 
Quality of Anesthesia as Judged by Operator Across Treatments 
52 49 
T-1 T-3 
Total number for each treatment indicates the sum of the responses of the operators for 
the 20 patients in each group based on the following rating scale: 
Excellent, 3; Good, 2; Fair, 1; and Poor, 0. 
I 
~ 
-J 
I 
Table XVII 
Record of Unfavorable Responses of Parents to Anesthetic Across Treatments and Intelligence Levels 
Difficulty managing child 
Unfavorable to this method of anesthesia 
Unfavorable response 
T-1 
0, 0, 2 
0, 0, 0 
2/20 
T-2 
0, 0, 0 
1, 0, 0 
1/20 
Column 1 are normal, Column 2 slow, Column 3 retarded under each treatment. 
Total number of unfavorable responses by intelligence levels: 
Normal 3/60 
Slow 1/60 
Retarded 4/60 
(Response percentages were: favorable 85o/o; unfavorable, l2o/o, unsure, 3%. 
T-3 
1 , 1 , 1 
0, 0, 1 
4/20 
One unsure response was recorded by the retarded in Treatment II and the normal in Treatment III. 
I 
~ 
co 
I 
DISCUSSION 
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In adapting the general anesthetic agent, ketamine, to pedo-
dontic out-patients, the main objective was to develop a method of 
administration which would provide safe, profound anesthesia with ' 
little or no unpleasant side effects and a short recovery period. Al-
though ketamine was shown in other studies to provide effective and 
safe anesthesia for short surgical or diagnostic procedures, many 
reports demonstrated long recovery times and a significant incidence 
fh 
. . 6,11,12,18,33 
o alluc inations and unpleasant erne rgenc e reactions tn adults. 
Accordingly, the three methods of administering ketamine in Treat-
ments I, II and III were designed to eliminate as many undesirable side 
effects as possible, A small dosage of ketamine was administered 
in each treatment, sufficient to take the patient to a light stage of 
anesthesia. Local anesthetic was necessary to avoid awakening the 
patient with a painful stimulus. 
Length of An esthesia 
The working time, or the length of anesthesia sufficient to 
allow the operator to provide careful, restorative dentistry with 
one injection of ketamine at 2 mg/lb IM, averaged 41. 10 to 59.70 + 
minutes (Table II). This length of time was sufficient to complete 
from 45% (Treatment II) to 90% (Treatment II) of the operative pro-
cedures without additional anesthetic. Although Treatments I and II 
compared very closely in length of working time, Treatment III re-
quired far fewer second injections. As a result, the performance of 
Treatment III was considered better in this respect. 
When the working times were compared across intelligence 
levels, no correlation could be found between any treatment and a 
longer or shorter working time. In an earlier pilot study using 
ketamine at 1 mg/lb, , some success was found in sedating normal 
children. However, ketamine at this dosage failed to provide 
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consistent anesthesia in mentally hand[capped or very young patients. 
As a result the dosage was increased to 2 mg/1~ to provide con-
sistent anesthesia in all groups of children. 
The working times of Treatment III are designated with a 
plus (+)to indicate that the actual working time would have been 
longer if the nitrous oxide analgesia had not been discontinued. 
Treatments I and II showed comparable average working times of 
42. 15 and 41.0 minutes. However, Treatment III demonstrated 
average working times of over 59.70 minutes. We can expect that 
if nitrous-oxide analgesia had been continued after the end of the 
procedures, significantly higher working times could be demonstrated 
than are shown here. 
Recovery Period 
Other studies have defined the recovery period as the time 
6, 12, 18, 19 
from the last injection of ketamine. Using that bas is in 
this study, the recovery times compare very closely to one another 
measured across treatments or intelligence levels (Table II). 
Treatment I recorded the lowest average recovery time of 134. 65 
minutes, whereas Treatments II and Ill compare very closely at 
143.00 and 144.55 minutes. However, these values do not seem to 
reflect themselves clinically as Treatment III consistently required 
few additional doses of ketamine. Therefore, if the length of time 
is recorded from the first injection of ketamine until the patient is 
fully recovered, regardless of the number of repeat injections, the 
following ave rage recovery times are no ted: Treatment I - 151. 6 0 
minutes, Treatment II- 156.60 minutes, Treatment III- 150.30 
minutes. Although these figure~ reflect more accurately the clinical 
picture, analysis shows that they are not statistically different due 
to the similarity of the means and to the wide variance of recovery 
times. 
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Intelligence Level 
When the mental and physical pre-anesthetic test was de-
veloped, it was expected that a correlation might be shown between 
the degree of mental disability and the dosage of ketamine necessary 
or the length of working and recovery time. Insignificant differences 
were detected in both working times and recovery times measured 
across intelligence levels. However, an interesting linear relation-
ship did occur among patients in all three treatments requiring more 
than one injection of ketamine (Table XIV). Children showing a 
greater degree of mental disability tended to require additional in-
jections less frequently. Additional injections of ketamine were given 
at a dosage of 1 mg/lb instead of 2 mg/lb. Since recovery time was 
measured from the time of the last injection, repeat injections of a 
lower dosage would tend to require shorter recovery periods. As 
the number of injections does not seem to increase the length of 
recovery time and later dosages are smaller, the differences in the 
length of recovery measured across intelligence may have been greater 
than the results suggest. The test scores correlated well with the 
three intelligence groupings as used in this study, with a mean of 4. 1 
for the retarded group, 10. 0 for the slow group, and 15. 8 for the 
normal group (Table XII). These values demonstrated statistical 
significance using Newman-Keuls "t" tests. 
If the patients were chosen randomly we should expect no 
significant differences in test scores measured across treatments. 
Although Treatments I and II show comparable test scores between 
groups, Treatment III shows a significantly higher (p<. 05) group 
mean. Therefore, the mental status or at least the cooperation for 
testing may have been slightly higher in Treatment Group III. Perhaps 
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this discrepancy can be explained by the problem of frequent nasal 
congestion and the difficulty in fitting a nitrous-oxide nose mask on 
a small child. Therefore, these patients who tended to score very 
low on the preoperative test seemed to be selected out of the group 
for Treatment III. 
Complications 
Any undesirable side effects of anesthesia in Treatments 
I, II or III were recorded on the Ketamine Evaluation Form (Exhibit 
#3 in Appendix). Only complications that occurred during anesthesia 
or the recovery period were generally noted. The exception was 
made for hallucinations as this was considered a sufficiently serious 
problem in other studies of adults to warrant careful evaluation in 
this investigation. 
Vomiting was a potential concern as aspiration of debris into 
b d d d . k . h . 31 the lungs can e emonstrate urtng etamtne anest esta. It 
was expected that by reducing the dosage from 1/2 to 1/3 that used 
. . 1 d 6 ' 9' 44 th . 1. t . ld b f th tn surgtca proce ures, ts comp tea ton cou e ur er 
reduced. In the pilot study, vomiting had been somewhat of a 
problem (9 per cent) with no attempt made to restrict the intake of 
food. During the present investigation, all parents were given 
specific instructions to avoid giving the patient food six hours before 
the anesthetic. This precaution dramatically reduced the incidence 
of vomiting, and if regurgitation did occur the amount of vomitus 
was small. 
A mechanical obstruction by the the tongue occurred in three 
instances in Treatment II, involving in all cases Down's Syndrome 
children. It is the author's opi~ion that this complication was related 
more to the unusual anatomy of the lower face and oral cavity of this 
type of child than to the method of treatment. Caution should be 
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exercised by anyone planning an anesthetic procedure on a Down's 
child without intubation. It was noted that during the obstruction 
period in these patients, a clear airway could be maintained by 
elevating the jaw or returning the patient to an upright sitting 
pas ition. 
The ease of administration and consistent good results of 
ketamine anesthesia tend to give the anasthetist a false sense of 
security. On occasion a laryngospasm can occur with serious 
6, 9 
results. Consequently, ketamine should not be administered by 
someone untrained in anesthesia principles and resuscitory pro-
cedures. In Treatment III, a single event of partial laryngospasm 
occurred in a healthy, normal 12-year-old female. The problem 
was relieve.d by administering 100 per cent oxygen with a positive 
pressure apparatus. The low incidence of hallucinations noted in 
this investigation was recorded over a 24-hour period using a Parent's 
Evaluation Form (Exhibit #4 in Appendix}. In previous studies, other 
investigators have reported fewer unpleasant emergence or post-
recovery psychic reactions in children given IM doses of 
9, 17' 33 1 £ h d ketamine. The overall resu ts o t is stu yare in agree-
ment here; the exception was a 23-year-old, 179 pound retarded 
patient. He was described by the parent as "reaching for things 
that weren't there" during the past recovery pe rio~. The hal-
lucinations did not continue the next day and no other ill effects were 
noted. 
Operator and Parent Response to Anesthesia 
The quality of anesthesia as judged by the operator was a 
matter of personal opinion. The operators consisted of clinical 
pedodontists with a background in treating handicapped children with 
and without sedation or anesthesia. If the patient was reasonably quiet 
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during the working period, the operators tended to be well satisfied 
with the method of anesthesia (Table XVI). In most cases all 
three treatments received either good or excellent appraisals by the 
pedodontists. No attempt was made to do a blind study regarding the 
particular treatment being used, as this would have been impractical 
considering the obvious nature of each form of treatment. 
The clinical pedodontis ts who participated in the investigation 
rated ketamine anesthesia high in comparison to other sedatives and 
hypnotics used in treating handicapped children. The main criticism 
of ketamine found in all three treatments was the length of recovery 
time. However, as the study progressed, it was noted that a certain 
amount of anesthetic inertia remained beyond the actual working 
period and if the ·procedure was near completion, reasonable co-
operation could be obtained by restraint instead of additional in-
jections of ketamine. Fewer total injections of ketamine helped to 
shorten the time until the patient was dis charged. During the latter 
period of anesthesia, the patient began to exhibit purposeless move-
ments and unintelligible sounds. Analgesia and amnesia continued 
until well into the recovery period. 
The parents were invited to comment favorably or un-
favorably on this method of sedation. No attempt was made to 
select out parents who regarded any form of sedation unfavorably. 
Most parents had seen their child at one time or another premedi-
cated for dental treatment, but for others the treatment with ketamine 
was their first experience with an anesthetic drug. Twelve per cent 
responded unfavorably, 85 per cent favorably, and 3 per cent were 
unsure. Considering the alternative of treatment with a hospital 
admission and a conventional gaseous anesthetic, these percentages 
were considered very satisfactory. 
SUMMARY AND CONCLUSIONS 
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An eleven-month study has compared the clinical performance 
of three methods of administering ketamine HCl in pedodontic out-
patients. Sixty behavior problem children were given ketamine and 
scopolamine (Treatment I), ketamine, scopolamine, and droperidol 
(Treatment II), or ketamine, scopolamine and nitrous oxide-oxygen 
analgesia (Treatment III) for restorative dental procedures. Each 
treatment group contained twenty randomly selected children. The 
treatments were administered by a uniform method and dental pro-
cedures of 60-90 minutes were completed. The length of effective 
anesthesia from the initial injection was measured and the length of 
recovery time from the last injection of ketamine (IM) was re-
corded. The patient was discharged when he was able to achieve the 
same score that he had achieved preoperatively on a series of mental 
and physical tests. Comparisons were made across treatments and 
intelligence levels (normal, slow, retarded) of the working time, 
recovery time, incidence of complications, and operator and parent 
res pons e. 
Treatment III (ketamine, scopolamine, and nitrous oxide) 
produced the longest working time as well as the shortest recovery 
time. Treatments I and II prcxluced shorter working times and longer 
recovery times. The incidence of complications and the quality of 
anesthesia as judged by the operator were very similar in all three 
treatments. The percentage of favorable responses to this form of 
anesthesia was comparably high in all three methods of treatment. 
Safe, effective anesthesia can be provided for behavior 
problem pedodontic out-patients using ketamine IM . providing the 
following procedures are used: 
1. Ketamine is administered in a dosage of 2 mg/lb together 
with scopolamine . 1 .- . 3 mg. Nitrous oxide may be used to 
supplement ketamine to lengthen working time. 
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2. Outside stimulation including light, tactile, or verbal should 
be reduced to a minimum. Local anesthetic should be em-
ployed. 
3. The patient should be on a fasting diet prior to anesthesia 
and the medical history should rule out a history of severe 
uncontrolled seizures or cerebrovascular ace id ent. A 
patient who presents with respiratory congestion or a cold 
should be rescheduled for a later time. 
4. All operative procedures should be completed using a rubber 
dam to minimize aspiration o£ debris and unnecessary stimu-
lation of the posterior pharyngx. 
5. To minimize the possibility of hallucinations, ketamine 
anesthesia should be limited to children. 
6. Ketamine is best suited to short operative procedures 
(<90 minutes) and should be administered only by operators 
with anesthesia training. 
APPENDIX 
Forms Used for Ketamine Anesthetic Procedure 
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Exhibit # 1 
INSTRUCTIONS FOR PARENTS CONCERNING SEDATION 
At your child's next appointment he will be given sedation to gain his 
cooperation and to enable his doctor to complete the dental treat-
ment. In order to make his appointment as comfortable as possible, 
please observe the following recommendations. 
l. If your child's appointment is in the morning, please restrict 
the diet to clear fluids for breakfast such as apple juice or 
soda. For an afternoon appointment, give no solid foods for 
six hours before the appointment time. This will help pre-
vent nausea experienced by some children. 
2. Be sure your child gets a good nights sleep before his appointment. 
3. After the appointment, your child will be awake but drowsy. 
Let him remain as quiet as possible. Loud talking, shaking, or 
other means to get your child's attention may only confuse him 
initially. If you have a long car ride ahead of you, your doctor 
may request that you remain until he feels your child is suf-
ficiently awake to travel. Your child may wish to sleep on and 
off for several hours or until the morning after his appointment. 
4. It is important that you complete the recovery evaluation form 
which will be given to you on the day of yotll'" appointment in 
order to evaluate your child's experience for future appointments. 
Riley Dental Clinic 
Motor Coordination 
a) Gait GFPV 
b) Entry to chair GFPV 
Memory Score 
l 2 3 4 5 
Finger-finger-test +-± 
Finger-nose+- ± 
Able to respond to 
simple commands 
a) Hold up hand 
b) Open mouth 
c) Close eyes 
Color discrimination 
Red Green Black 
Number of fingers 
a) three 
b) one 
c) two 
Exhibit #2 
Physical and Mental Measurement Form 
l. Motor Coordination 
a} Gait GFPV 
b) Exit fromchair GFPV 
2. Memory Score 
1 2 3 4 5 
3. Finger-finger + - ± 
Finger-nose + - ± 
4. Able to respond to 
simple commands 
a} Hold up hand 
b) Open mouth 
c) Close eyes 
5. Color Discrimination 
Red Green Black 
6. Number of fingers 
a) three 
b) one 
c) two 
l. Motor Coordination 
a) Gait GFPV 
b) Entry from chair GFPV 
2. Memory Score 
1 2 3 4 5 
3. Finger-finger+-± 
Finger-nose+-± 
4. Able to respond to 
simple commands 
a) Hold up hand 
b) Open mouth 
c) Close eyes 
5. Color Discrimination 
Red Green Black 
6. Number of fingers 
a) three 
b) one 
c) two 
1. Motor Coordination 
a) Gait GFPV 
b) Exit from chair GFPV 
2. MemoryScore 
l 2 3 4 5 
3. Finger-finger+- ± 
Finger-nose + - ± 
4. Able to respond to 
simple commands 
a) Hold up hand 
b) Open mouth 
c) Close eyes 
5. Color Discrimination 
Red Green Black 
6. Number of fingers 
a) three 
b) one 
c) two 
I 
U1 
00 
I 
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Exhibit #3 
Ketamine Evaluation Form 
Code Number 
---
(Please fill out completely) Date 
-------
Patient's Name;· ---------------Age __ Weight ____ _ 
Recent Medication: 
-------------------------------------
Mental Status: a) normal b) slow c) retarded 
Would the child cooperate for normal x-rays? YES NO 
Initial Observation: a) cooperative b) apprehensive c) fearful 
d) excited and uncooperative 
Blood Pres sure 
Pulse 
Respiration 
Before During After Procedure 
Ketamine HCl Scopolamine Other 
Induction Dose 
(time) 
Second Injection 
(time) 
Third Injection 
(time) ' 
What was onset time of anesthesia: minutes 
Maintenance: 
Second Injection (time) 
Third Injection (time) 
Course: 
Local anesthesia 
Start of Procedure 
During Procedure 
Near end of procedure 
After the procedure 
--------------------
Quiet and 
Cooperative 
Ketamine Other 
Movement and Uncoopera-
Cooperative tive 
Behavior deteriorated after first injection: 10 min_20min_30 min 
40 min 60 min 
Recovery: _______________________________________ __ 
Complications: Facial Erythema Dreaming ____ _ 
Nausea Other (Specify) 
--------------------
Do you feel sufficient dosage was administered? YES NO 
Description of procedure: _________________________ ~ 
Anesthesia was: a) excellent 
RECOMMENDATIONS=---------------------
b) good c) fair d) poor 
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Exhibit #4 
Sedation Questionnaire Form 
Name 
------------------------------Date 
---------------------------------
Please complete the following questions and return the form im-
mediately to Riley Dental Clinic. This is important in the future care of 
your child and becomes a part of his permanent medical record. 
1. When you left the dental clinic was your child: 
a} asleep b) crying c) normal d) restless e) drowsy f) dreaming 
2. On the way home, was your child: 
a) asleep b) awake but drowsy c) awake but restless d) dreaming 
e) about normal 
3. Did your child vomit on the way home or after you arrived home? 
4. How long did it take to get home after leaving the clinic? 
------
5. When you arrived home did your child walk into the house? YES NO 
6. Did your child report any dreams: YES NO 
If s o pleas e d e s c rib e 
-------------------------------------------------
7. Did you have any difficulty managing your child after you got home? 
YES NO 
8. Did your child want to sleep? YES NO 
9. If your child slept, until what time did he (or she) sleep? 
10. At what time did your child resume normal activities? 
o'clock 
---
o'clock 
-----
11. How did your child describe his dental experience? 
12. Did you notice anything in your child's behavior that was unexpected? 
YES NO 
If so, please specify 
-------------------------------------------------
13. Did your child have a temperature? YES NO 
14. Do you feel that this method of sedation was favorable or unfavorable 
for your child's dental treatment? 
15. Additional Comments: 
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ABSTRACT 
AN EVALUATION OF KETAMINE HYDROCHLORIDE 
IN PEDODONTIC OUTPATIENTS 
Daniel N. O'Brien 
Indiana University School of Dentistry 
Indianapolis, Indiana 
The need for a safe but effective agent to sedate dental patients 
who are severe behavior management problems prompted this investi-
gation of ketamine HCl. Ketamine HCl is a general anesthetic agent 
with the unique property of selectively depressing the higher centers 
of the brain without adversely affecting respiration or cardiac output. 
Sixty behavior problem pedodontic patients were selected at 
random and placed in one of three groups to receive the following 
treatments: Treatment I - ketamine HCl and scopolamine; Treatment 
II - ketamine, scopolamine, and d roper idol, and Treatment III -
ketamine, scopolamine, and nitrous oxide-oxygen analgesia. 
Each treatment group received ketamine HCl 2 mg/lb and 0. 1 -
0.3 mg scopolamine. The second two treatment groups were sup-
plemented with droperidol o 025 mg/lb or nitrous oxide-oxygen (20-50%) 
to maintain anesthesia. 
The patients were given a series of pre and post-treatment mental 
and physical tests and were cons ide red completely recovered when they 
could equal their pre treatment test scores. Routine dental restorative 
procedures limited to one and one-half hours were carried out with the 
use of the ruber dam. 
Onset of anesthesia was five minutes for all three treatment 
groups. Treatment III showed a significantly longer working time but 
recovery times were not significantly different between groups. Ketamine 
HCl was determined to be a safe, effective agent for use in pedodontic 
outpatients provided prescribed techniques are followed. Complications 
were infrequent and minor and parental response was considered 
satisfactory. 
